Apalutamide 60mg Suppliers & Bulk Manufacturers
Available Forms: Tablets
Available Strengths: 60mg
Reference Brands: ERLEADA (USA/EU)
Category: Oncology Cancer Care
Apalutamide is a next-generation androgen receptor inhibitor used for the treatment of prostate cancer, including non-metastatic castration-resistant and metastatic castration-sensitive forms. It works by blocking the effects of androgens, hormones that promote the growth of prostate cancer cells. Administered orally, Apalutamide is often used in combination with androgen deprivation therapy (ADT). Erleada has become an important option in prolonging survival and delaying disease progression in prostate cancer patients.
Apalutamide — third party manufacturing & bulk supply
Apalutamide 60mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
Indicative minimum order quantity
Apalutamide is supplied as Tablets — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.
Manufacturers of Apalutamide listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.
Request a quote for Apalutamide →Frequently Asked Questions
Apalutamide is used for the treatment of prostate cancer, including non-metastatic castration-resistant and metastatic castration-sensitive prostate cancer. It works by blocking androgen receptors, which prevents testosterone from stimulating the growth of cancer cells, helping to slow disease progression and improve patient outcomes.
Apalutamide is made from Apalutamide, a next-generation androgen receptor inhibitor that selectively binds to androgen receptors in prostate cancer cells to inhibit their activity.
The trade name of Apalutamide is Erleada.
Apalutamide (Erleada) is manufactured by Janssen Biotech, a division of Johnson & Johnson, and distributed globally under approved regulatory pathways.
The generic name of Apalutamide is Apalutamide.
The brand name of Apalutamide is Erleada.
Apalutamide is manufactured in the United States and Europe by Janssen Biotech under GMP-certified facilities.
Related Products
Eribulin Mesylate
Strength:
0.44 mg/mL
Form: Injection
Reference Brands: HALAVEN (USA/EU)
View Details
Epcoritamab-Bysp
Strength:
4 mg/0.8 mL, 48 mg/0.8 mL
Form: Injection
Reference Brands: EPKINLY (USA)
View Details
Methotrexate
Strength:
Tablets: 2.5 mg, 5 mg, 10 mg, 15 mg; IV/IM: 25 mg/mL
Form: Oral tablets, Injection (IV and IM)
Reference Brands: Trexall®, Rheumatrex® (EU & US)
View Details
Paclitaxel Liposomal
Strength:
30 mg/5 mL, 100 mg/16.7 mL, 300 mg/50 mL
Form: Injection (IV administration)
Reference Brands: Taxol®, Abraxane® (US & EU)
View Details
Topotecan Capsule
Strength:
Capsule: 1 mg, 2.5 mgL
Form: Oral capsules
Reference Brands: Hycamtin® (EU & US)
View DetailsQuick Response Guaranteed | Verified Suppliers
